Pharmaceutical industry equipment occupies the mainstream of reorganization of industrial structure
Laser Metal Cutting Machine, for metal materials, carbon steel, stainless steel, non-metal materials, mdf, rubber, paper etc. With RDCAM control system , reci tube, stepper motor, size mainly 1325, 1530. other size also can be provided.
1325 laser cutter
metal cutting sample
non metal sample
Laser type is CO2.
Delivery time around 15 working days after receive payment.
Metal Laser Machine,Non Metal Laser Machine,Metal Laser Cutter,Laser Metal Cutting Machine Shandong Leapion Machinery Co., Ltd. , http://www.leapionlaser.com
“We encourage companies to go ahead of the industry, especially in industrial development. Past experience has repeatedly verified that companies often go before the industry standards.†said one industry right person. I believe that in the future in the transformation of the new version of GMP, domestic pharmaceutical equipment will occupy an increasingly mainstream position. The development of China's pharmaceutical industry will get better and better, and it will go healthier.
Mainstream of new GMP transformation of pharmaceutical equipment In the new GMP reform, not only pharmaceutical companies have grown up, domestic equipment companies have emerged as much as the superiority of foreign imported equipment, and encourage companies to go ahead of industry regulations. There is also a precedent in FDA regulation, and he thinks this is very worthy of recognition.
At present, industrial design is a common weak link in the industry. It is the main difference between developed enterprises in China and Europe and the United States. It is also a key technology for the domestic industry to be promoted. Only by thoroughly understanding and mastering the design of industrial systems can we quickly upgrade our industry. It is the only way for industrial progress, and it is also the only way to fundamentally solve the backwardness of China's industries. In fact, a number of high-quality domestically-manufactured equipment are still appearing in the new GMP reform that has passed the certification.
In the reform of the new version of GMP, domestic pharmaceutical equipment will occupy an increasingly mainstream position. More and more high-quality domestically produced pharmaceutical equipment with independent intellectual property rights will emerge in the upgrading of technological equipment in the pharmaceutical industry. Enterprises that fail to pass the certification will not be able to guarantee supply through certification in the short term, but will be eliminated by the market. The inevitable outcome.
Industrial structure, elimination of outdated production capacity According to the current data, Zhong Qian, a member of the Academic Committee of the China Pharmaceutical Industry Research Institute, believes that although the number of certified sterile preparation companies is small, the certified production capacity is relatively large and they have not passed certification. Under the background that enterprises will be forced to suspend production next year, the companies that have already passed will supply 100% of the market, and next year will usher in the sales season.
Overcapacity has always been a prominent problem in the development of China's pharmaceutical industry. It can also be seen from the newly revised pharmaceutical GMP certification by aseptic manufacturers, fully demonstrating the necessity of adjusting the industrial structure of China's pharmaceutical industry and eliminating backward production capacity.
